Insider buying last 90 days
No open-market insider purchases were filed for STVN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every STVN insider filing, plotted on the chart in Gekko.Open STVN in Gekko
NYSE: STVN
Stevanato (STVN) Stock Analysis & Forecast
Sep 28 close
$21.41+0.28 (+1.3%)
Gekko Brief
AI summaryStevanato closes at $21.41, up 1.3% on the session and sitting above both its 50-day average of $20.96 and its 200-day average of $18.25, with the 50-day above the 200-day. The GekkoIndex reads 56.1, placing the stock in the Neutral zone with a five-day change of 1.9. Gekko Fair Value stands at $22.42, putting the current price 4.5% below that mark. Over the past month the stock is down 4%, while the three-month and six-month returns stand at 23.3% and 59.4%, and the one-year return is -14.7%. The 52-week range spans $12.89 to $27.99.
The next earnings report is due 5 November 2026, before the open, 37 days away and outside a typical 20-trading-day holding window; the prior report on 5 March 2026 showed EPS of $0.21 against an estimate of $0.17, with a -11.9% reaction, and the company has beaten estimates in 5 of the last 8 quarters. Seasonality from this point in the calendar shows a 20-trading-day average of -5.5% across 5 years, rising in 1 of those years. Consensus among 6 firms shows 4 buy and 2 hold ratings with a $24.68 target, representing 15.3% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Stevanato price vs fair value
Close $21.41200-day averageGekko Fair Value $22.42
Stevanato quick facts
- Market cap
- $5.85B
- P/E ratio
- 38.9
- Forward P/E
- 29.2
- EPS, TTM
- $0.55
- Revenue, TTM
- $1.23B
- Profit margin
- 11%
- Dividend yield
- 0.00%
- Beta
- 0.75
- Volume
- 306,631 avg 318,562
- 1-year return
- −14.7%
- Typical daily move
- ±4.4%
- Typical 20-day move
- ±8%
- 50-day average
- $20.96
- 200-day average
- $18.25
- Next earnings
- Nov 5 before open
- Shares outstanding
- 49.83M
Stevanato swing-trade checklist
Stevanato scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $21.41 is above the 50-day ($20.96) and 200-day ($18.25) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
56.1, Neutral
Reading 56.1 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
4.5% below
Price is within 5% of Gekko Fair Value (4.5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−5.5% on average
From this point in the calendar, the next 20 trading days averaged −5.5% over 5 years, rising in 1 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Stevanato stock chart and price history
Stevanato closed at $21.41 on Sep 28, 2026, −14.7% over the past year, inside a 52-week range of $12.89 to $27.99.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −4.0%
- 3 months
- +23.3%
- 6 months
- +59.4%
- 1 year
- −14.7%
The full STVN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open STVN in Gekko
Follow Stevanato through every session
Put STVN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track STVN in GekkoFree for 7 days. No credit card required.
About Stevanato
Stevanato develops and produces packaging and delivery equipment used across the pharmaceutical and healthcare fields. Customers rely on it for containment products, drug delivery systems, and medical devices, as well as diagnostic and analytical support, and it has built recognition around this mix of components serving drugmakers and health providers.
Beyond these products, the company builds machinery for jobs like inspecting finished goods visually, assembling parts, packaging output, and shaping glass. It sits within a larger corporate group, operating as a subsidiary of Stevanato Holding S.R.L., while carrying out its manufacturing and engineering work under its own brand.
The company dates back to 1949 and keeps its principal base in Piombino Dese, Italy. Its stock trades on the NYSE under the ticker STVN.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- stevanatogroup.com
Stevanato GekkoIndex: the smart money zone
Stevanato’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.1, in the Neutral zone, up 1.9 points over five sessions.
56.1Neutral
Up 1.9 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 40 | +0.8% | +0.7% | ||
| Accumulation | 252 | +1.0% | +0.4% | ||
| Neutral (current zone) | 353 | −0.6% | −1.0% | ||
| Distribution | 19 | −4.0% | −3.7% | ||
| Selling | 8 | Too few readings yet | |||
Average STVN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the STVN price, zone by zone.Track STVN in Gekko
Is Stevanato stock overvalued? Gekko Fair Value
Stevanato trades 4.5% below Gekko Fair Value of $22.42, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Stevanato shares are worth, recalculated every trading day.
$22.42
Gekko Fair Value, Sep 26, 2026
4.5% below fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open STVN in Gekko
Stevanato insider and Congress trading
No open-market insider purchases were filed for Stevanato, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in STVN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for STVN, plotted on the chart in Gekko.Open STVN in Gekko
Stevanato earnings: next date and track record
Stevanato reports on Nov 5, 2026, before the open (37 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, 37 days away
- EPS estimate
- $0.18
- Revenue estimate
- $365.9M
5 of 8reports beat the EPS estimate
±10.6%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Mar 5, 2026 AI summary
- What they said
- Stevanato Group reported 9% constant currency revenue growth for fiscal 2025, driven by strong performance in high-value solutions which increased 29% and represented 46% of total revenue. The Biopharmaceutical and Diagnostic Solutions segment delivered double-digit growth, while gross profit margin expanded 160 basis points. GLP-1 related revenue grew over 50% and now accounts for 19-20% of total company revenue, with the Nexa syringe being the fastest-growing product.
- Guidance
- Management expects GLP-1s to provide meaningful tailwinds as demand continues growing. The company is expanding cartridge capacity to meet higher-than-expected demand and anticipates continued benefits from the evolving GLP-1 market over the next decade.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 5, 2026 | $0.21 est $0.17 | $407.0M est $391.3M | −11.9% |
| Nov 6, 2025 | $0.14 est $0.13 | $355.1M est $385.5M | −3.6% |
| Aug 5, 2025 | $0.11 est $0.10 | $329.7M est $343.2M | −6.0% |
| May 8, 2025 | $0.10 est $0.09 | $281.3M est $301.6M | +10.1% |
| Mar 6, 2025 | $0.19 est $0.18 | $342.3M est $268.2M | +13.1% |
| Nov 5, 2024 | $0.11 est $0.13 | $304.7M est $345.1M | +16.4% |
| Aug 6, 2024 | $0.09 est $0.10 | $279.1M est $325.4M | +4.4% |
| May 9, 2024 | $0.08 est $0.11 | $253.5M est $300.5M | −18.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Stevanato stock forecast and analyst price targets
Analysts’ average 12-month price target for Stevanato is $24.68, +15.3% from the last close, from 6 firms rating the stock in the last 90 days.
$24.68consensus 12-month target, +15.3% from the last close
Now $21.41Avg $24.68
Low $20High $26
Each firm’s latest rating in the last 90 days: 6 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Morgan Stanley | $20 | −6.6% |
| Sep 21 | Morgan Stanley | $20 | −6.6% |
| Sep 9 | UBS | $23 | +7.4% |
| Aug 31 | Morgan Stanley | $20 | −6.6% |
| Aug 24 | Morgan Stanley | $20 | −6.6% |
−1.0%average 20-day move after past Neutral readings
−5.5%average move over the next 20 trading days in the last 5 years
±4.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Stevanato seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Stevanato averaged −5.5% across the last 5 years, rising in 1 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.3% | 2 of 5 |
| Next 10 trading days | −1.9% | 2 of 5 |
| Next 15 trading days | −2.4% | 2 of 5 |
| Next 20 trading days | −5.5% | 1 of 5 |
| Next 30 trading days | −6.5% | 1 of 5 |
For scale, STVN’s typical 20-trading-day move in either direction is about 8%.
Stevanato market cap and key statistics
Stevanato’s market cap is $5.85B, with a P/E ratio of 38.9 and revenue of $1.23B over the last twelve months.
Valuation
- Market cap
- $5.85B
- P/E ratio
- 38.9
- Forward P/E
- 29.2
- EPS, TTM
- $0.55
- Gekko Fair Value
- $22.42
Trading
- Volume
- 306,631
- Avg volume, 20 days
- 318,562
- 52-week high
- $27.99
- 52-week low
- $12.89
- Shares outstanding
- 49.83M
Financials
- Revenue, TTM
- $1.23B
- Profit margin
- 11%
- Return on equity
- 9.1%
- Quarterly earnings growth, YoY
- −26.5%
Risk and income
- Beta
- 0.75
- Typical daily move
- ±4.4%
- Typical 20-day move
- ±8%
- Dividend yield
- 0.00%
Stevanato stock news this week
1 headline about Stevanato from the past week, newest first, each linking to the publisher.
- STVN - Stevanato Group Spa Volatility & GreeksFinviz, Sep 21
Stevanato peers
Stevanato’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Stevanato stock FAQ
What is Stevanato’s market cap?
Stevanato’s market cap is $5.85B at the Sep 28, 2026 close of $21.41, with 49.83M shares outstanding. The shares trade on a P/E ratio of 38.9.
What is the Stevanato stock forecast?
The consensus analyst 12-month price target for Stevanato is $24.68, +15.3% from the last close. Of the 6 firms that rated the stock in the last 90 days, 4 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Stevanato stock overvalued or undervalued?
On Gekko’s estimate Stevanato is about fair value: the Sep 28, 2026 close of $21.41 is 4.5% below Gekko Fair Value of $22.42. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Stevanato report earnings next?
Stevanato is expected to report on Nov 5, 2026, before the market opens (37 days away). Analysts expect earnings of $0.18 per share on revenue of $365.9M. Stevanato beat the earnings estimate in 5 of its last 8 reports, moving 10.6% on average across the report.
What is Stevanato’s 52-week high and low?
Stevanato’s 52-week high is $27.99 and its 52-week low is $12.89; it closed at $21.41 on Sep 28, 2026, −14.7% over the past year. Over the last five years the shares peaked at $36.30 on Aug 9, 2023.
Is Stevanato stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and earnings risk), 2 as mixed (gekkoindex and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Stevanato the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.